FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents a combination of leucine source and ω-3 polyunsaturated fatty acid source applicable in therapeutic or preventive treatment of hypercalcemia.
EFFECT: invention provides extending the range of products applicable in the therapeutic or preventive treatment of hypercalcemia.
19 cl, 8 dwg, 2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
NUTRITIVE COMPOSITION FOR MAMMAL IMMUNE SYSTEM IMPROVEMENT | 2009 |
|
RU2525429C2 |
APPLICATION OF NUTRIENT COMPOSITION FOR MUSCULAR FUNCTION AND DAILY ACTIVITY IMPROVEMENT | 2009 |
|
RU2636162C2 |
NUTRITIONAL COMPOSITION FOR IMPROVEMENT OF MUSCLE FUNCTIONS AND DIURNAL ACTIVITY | 2009 |
|
RU2506825C2 |
TREATMENT OF TRAUMATIC BRAIN INJURY | 2018 |
|
RU2771277C2 |
USING SOLUBLE FOOD FIBRES AGAINST MUSCULAR ATROPHY | 2006 |
|
RU2450815C2 |
COMBINATIONS AND COMPOSITIONS CONTAINING FATTY ACIDS AND AMINO ACIDS, THEIR APPLICATION FOR PREVENTION AND DELAY OF PROGRESSING OR TREATMENT OF DIABETES AND DIABETES ASSOCIATED DISEASES AND CONDITIONS, METHOD OF WEIGHT REDUCTION IN MAMMAL, KIT | 2004 |
|
RU2356247C2 |
LIQUID ENTERAL NUTRIENT COMPOSITION SUITABLE FOR ENTERAL FEEDING, MINIMISING UPPER AND LOWER GASTROINTESTINAL COMPLICATIONS | 2010 |
|
RU2516782C2 |
NUTRITIONAL COMPOSITION FOR IMPROVING CEREBRAL FUNCTION IN PHENYLKETONURIA | 2014 |
|
RU2690660C2 |
NON-MEDICAL INCREASE OR MAINTENANCE OF BODY WEIGHT OF A MAMMAL | 2011 |
|
RU2647461C2 |
LEUCINE-ENRICHED COMPOSITION | 2006 |
|
RU2428977C2 |
Authors
Dates
2015-07-10—Published
2010-05-27—Filed